While the Novo Nordisk case shows the risks of powerful fund ownership, Niels Peter Louis-Hansen has announced his plan to put his ownership stake in Coloplast into a new fund.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
While the Novo Nordisk case shows the risks of powerful fund ownership, Niels Peter Louis-Hansen has announced his plan to put his ownership stake in Coloplast into a new fund.